TFE3 fusion proteins are the oncogenic drivers of translocation renal cell carcinoma but their mechanism of action remains ...
PB Fintech's Rs 696-crore foray into building a network of cost-controlled hospitals has sparked mixed reactions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback